In patients with gastric carcinoma the determination of the activities of some cellular and humoral factors may reflect the immunological state of the patient, the stage and extent of the disease, and help estimate the effects of treatment and prognosis. Moreover, experimental studies and preliminary clinical trials of some of these cellular elements and humoral factors in the treatment of gastric carcinoma have opened a new field of adoptive immunotherapy.
展开▼
